NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-OD-24-010 from the NIH Guide for Grants and Contracts
Notice NOT-AI-23-074 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DK-25-003 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications for Silvio O. Conte Digestive Diseases Research Core Centers (DDRCCs). The DDRCCs are part of an integrated program of digestive and liver diseases research support provided by the NIDDK. The purpose of this Centers program is to bring together basic and clinical investigators as a means to enhance communication, collaboration, and effectiveness of ongoing research related to digestive and/or liver diseases within the NIDDK's mission. DDRCCs are based on the core concept, whereby shared resources aimed at fostering productivity, synergy, and new research ideas among the funded investigators are supported in a cost-effective manner. Each proposed DDRCC must be organized around a central theme that reflects the focus of the digestive or liver diseases research of the Center members. The central theme must be within the primary mission ofthe NIDDK, and not thematic areas for which other NIH Institutes or Centers are considered the primary source of NIH funding.
Notice NOT-AG-23-063 from the NIH Guide for Grants and Contracts
Notice NOT-OD-24-013 from the NIH Guide for Grants and Contracts
Notice NOT-DA-23-038 from the NIH Guide for Grants and Contracts
Notice NOT-AG-23-065 from the NIH Guide for Grants and Contracts
Notice NOT-AG-23-062 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DA-25-013 from the NIH Guide for Grants and Contracts. The scientific objective of this Funding Opportunity Announcement is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Understanding the involvement of inflammasomes in virus and drug-induced immune activation may help identify molecular markers and CNS immune cells associated with HIV-1 infection or disease progression among substance abuse populations, as well as identify novel therapies to target inflammasome activation or suppression to treat neuroinflammation and immune dysregulation aroused in these processes.
Funding Opportunity RFA-DA-25-012 from the NIH Guide for Grants and Contracts. The scientific objective of this Notice of Funding Opportunity is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Understanding the involvement of inflammasomes in virus and drug-induced immune activation may help identify molecular markers and CNS immune cells associated with HIV-1 infection or disease progression among substance abuse populations, as well as identify novel therapies to target inflammasome activation or suppression to treat neuroinflammation and immune dysregulation aroused in these processes.
Notice NOT-CA-23-097 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-24-045 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to support research projects that aim to further understanding of the developmental trajectories of late talking children by leveraging existing data and creating open and shared data resources to aid in identifying patterns and predictors of developmental outcomes in late talking children, and exploring potential underlying mechanisms, risk factors, and sequalae.
Funding Opportunity RFA-AA-23-004 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks applications for research center grants to conduct high-impact research on alcohol and HIV/AIDS. Through this NOFOA, NIAAA seeks to encourage research applications aimed to address the impact of alcohol use (and related other substance use, mental health, and pharmacological/medication complications) on the most important challenges for controlling and ending HIV/AIDS pandemic. This announcement reflects the high priority topics for research described in the NIH Office of AIDS Research FY2021-FY2025 Strategic Plan for HIV and HIV-Related Research https://www.oar.nih.gov/sites/default/files/NIH_StrategicPlan_FY2021-2025.pdf and research aspects included in the National HIV/AIDS Strategy (2022-2025) https://www.hiv.gov/federal-response/national-hiv-aids-strategy/national-hiv-aids-strategy-2022-2025 focused on ending the HIV epidemic among substance users (c.f. alcohol and drug). In particular, translational studies of alcohol use as a risk factor impacting HIV prevention, treatment effectiveness, and HIV-related comorbidities are strongly encouraged.
Funding Opportunity RFA-MD-24-001 from the NIH Guide for Grants and Contracts. The purpose of the Research Centers in Minority Institutions (RCMI) Program is to expand the national capacity for research in the health sciences by providing cooperative agreement support to institutions that offer doctorate degrees in the health professions or in a health-related science and have a documented historical and current mission or historical commitment to educating underrepresented students, and for institutions that provide clinical services to medically underserved communities. The primary goals of RCMI specialized center awards are to: (1) enhance institutional research capacity to conduct world-class basic biomedical, behavioral, population and/or clinical research; (2) enable all levels of investigators at the recipient institution to become more successful in obtaining competitive extramural support, especially from NIH, for research on diseases and conditions that disproportionately impact populations that experience health disparities; (3) foster institutional environments conducive to research career development and enhancement for post-doctoral fellows, junior faculty, and other early-stage investigators; (4) enhance the tools for and conduct of research generally and specifically for improving minority health and reducing health disparities; and (5) establish sustainable partnerships with community-based organizations to promote research efforts and the dissemination of research findings.
Notice NOT-CA-23-096 from the NIH Guide for Grants and Contracts
Notice NOT-NS-23-112 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DA-24-030 from the NIH Guide for Grants and Contracts. The goal of this NOFO is to support the development and application of innovative ex-vivo imaging methods, along with necessary tissue procurement, processing and computation pipelines, to enable the spatial analysis and molecular annotation of intercellular interactions in CNS HIV infection, persistence, and associated neuropathology.
Notice NOT-DE-24-005 from the NIH Guide for Grants and Contracts
Notice NOT-DE-24-004 from the NIH Guide for Grants and Contracts
Notice of Special Interest (NOSI): Research Projects to Develop Oncoaging Models for Cancer Research
Notice NOT-CA-23-092 from the NIH Guide for Grants and Contracts